Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease

无症状的 正电子发射断层摄影术 疾病 认知 神经退行性变 阿尔茨海默病 纵向研究 匹兹堡化合物B 阿尔茨海默病神经影像学倡议 标准摄取值 淀粉样蛋白(真菌学) 肿瘤科 医学 认知功能衰退 心理学 内科学 痴呆 病理 核医学 精神科
作者
Philip S. Insel,Niklas Mattsson,Oliver Langford,Vincent M. Caruso,Antoine Leuzy,Christina B. Young,Adam L. Boxer,Paul Aisen,Reisa A. Sperling,Elizabeth C. Mormino,Michael Donohue
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:82 (10): 985-985 被引量:12
标识
DOI:10.1001/jamaneurol.2025.2974
摘要

Importance: Developing disease-modifying treatments is a priority for Alzheimer disease research. Objective: To determine the potential of plasma phosphorylated tau 217 (p-tau217) and tau positron emission tomography (PET) to assess disease modification in treatment trials. Design, Setting, and Participants: This diagnostic/prognostic study used longitudinal data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study collected from April 2014 to June 2023. Recruited from 67 sites in the US, Canada, Australia, and Japan, participants included older individuals (age 65-85 years) who were cognitively unimpaired at screening and underwent an amyloid PET scan. Participants without elevated amyloid PET were included from a companion to the A4 study, the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) study. Exposure: 18F-florbetapir PET imaging. Main Outcomes and Measures: 18F-florbetapir PET imaging was used to classify participants as having elevated amyloid β (Aβ+). Measures of tau included longitudinal plasma p-tau217 and 18F-flortaucipir PET. Cognition was assessed using the Preclinical Alzheimer Cognitive Composite (PACC). Results: A total of 1169 individuals were included from A4 Study and 538 without elevated amyloid PET were included from the LEARN Study. Among these 1707 participants, the baseline mean (SD) age was 71.5 (4.7) years, 1024 (60%) were female, and 683 (40%) male; 1169 participants were Aβ+, and the mean (SD) Mini-Mental State Examination score was 28.8 (1.2). The tau PET substudy included 443 participants; plasma p-tau217 levels were available for 1643 participants. The largest effect size of longitudinal tau PET accumulation at 36 months in Aβ+ participants was in the inferior temporal gyrus. Baseline associations with longitudinal change in PACC score in Aβ+ participants were strongest in the entorhinal cortex (correlation [ρ] = -0.55; 95% CI, -0.63 to -0.45) and plasma p-tau217 levels (ρ = -0.47; 95% CI, -0.56 to -0.37). Tau PET changes in frontoparietal regions were strongly correlated with concurrent cognitive changes. Levels of plasma p-tau217 increased significantly in Aβ+ participants before showing significant deceleration (χ2 = 21.7; P < .001) and were not associated with concurrent cognitive change in the tau PET substudy (ρ = -0.03; 95% CI, -0.23 to 0.16) but were modestly associated with concurrent cognitive changes in the full plasma sample (n = 1119; ρ = -0.24; 95% CI, -0.34 to -0.14). Conclusions and Relevance: This study found that tau PET is valuable for both prognostic and real-time tracking of disease progression. Plasma p-tau217 predicts cognitive changes prior to overt cognitive impairment and can efficiently guide participant selection. Imaging-based tau measures may enhance detection of disease-modifying effects and refine therapeutic targets in future Alzheimer disease trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
不知道叫啥完成签到 ,获得积分10
1秒前
cssc完成签到,获得积分10
2秒前
华仔的应助被科研通管家采纳,获得10
2秒前
学习万岁完成签到 ,获得积分10
5秒前
mengmenglv完成签到 ,获得积分0
6秒前
9秒前
甜蜜的紫菜完成签到,获得积分10
17秒前
顺利毕业完成签到 ,获得积分10
20秒前
24秒前
ADChem_JH完成签到,获得积分10
30秒前
33秒前
aRuuuu完成签到 ,获得积分10
34秒前
35秒前
玩命的芸遥完成签到,获得积分10
36秒前
39秒前
zaq123456完成签到 ,获得积分10
39秒前
40秒前
yyyyy发布了新的文献求助10
47秒前
mianmian186发布了新的文献求助10
48秒前
乐正怡完成签到 ,获得积分0
51秒前
1分钟前
xiaoyi完成签到 ,获得积分10
1分钟前
小红帽完成签到 ,获得积分10
1分钟前
侯子完成签到 ,获得积分10
1分钟前
1分钟前
科目三的应助被Wang采纳,获得10
1分钟前
故意的冷安完成签到,获得积分10
1分钟前
mianmian186发布了新的文献求助30
1分钟前
lucinda完成签到 ,获得积分10
1分钟前
lishuhua完成签到 ,获得积分10
1分钟前
1分钟前
仁爱觅风完成签到 ,获得积分10
1分钟前
科研通AI6.3的应助被mianmian186采纳,获得10
2分钟前
小二郎的应助被科研通管家采纳,获得10
2分钟前
xiaolizi的应助被科研通管家采纳,获得40
2分钟前
yangsheng完成签到 ,获得积分10
2分钟前
阳光灭绝完成签到,获得积分10
2分钟前
jiuzhijiu完成签到,获得积分10
2分钟前
Jasper的应助被微山采纳,获得10
2分钟前
诸葛平卉完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190320
求助须知:如何正确求助?哪些是违规求助? 9577417
关于积分的说明 21852481
捐赠科研通 7788909
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482975